LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

article, cancer, lung, pubmed, cas, google, scholar, japan, patients, afatinib, cell, gefitinib, department, pharmaceutical, skin, rash, nonsmall, okayama, study, erlotinib, medicine, response, advanced, nonsmallcell, egfr, mutations, receptor, phase, oncol, clin, respiratory, katsuyuki, epidermal, growth, factor, received, med, hospital, privacy, cookies, content, chemotherapy, development, monotherapy, egfrmutant, hotta, access, engl, trial, publish,

Topics {✒️}

month download article/chapter small-cell lung cancer article cancer chemotherapy advanced egfr mutation-positive full article pdf related subjects chugoku central hospital small study demonstrated privacy choices/manage cookies metastatic lung adenocarcinoma okayama university hospital included skin rash lung cancer kawasaki medical school phase iii study phase ii study eli lilly japan article kudo treating egfr-mutant response evaluation criteria adverse event profile revised recist guideline ethics declarations conflict advanced bronchioloalveolar carcinoma conditions privacy policy egfr mutations erlotinib versus chemotherapy european economic area phase ii trial article log daiichi-sankyo pharmaceutical accepting optional cookies naoyuki nogami toshiyuki kozuki shingo harita toshiaki okada common adverse events check access instant access afatinib versus cisplatin advanced solid tumours egfr-mutant nsclc population pharmacokinetics/pharmacodynamics article cite gefitinib 250 mg daily received afatinib therapy journal finder publish wu yl naohiro oda lung cancers

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience
         description:Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are now key agents in treating EGFR-mutant non-small cell lung cancer (NSCLC). The efficacy of gefitinib or erlotinib monotherapy can be predicted by the development of a skin rash. However, it has not been fully evaluated if this is the case with afatinib monotherapy. We retrospectively studied 49 consecutive patients with EGFR-mutant NSCLC who received afatinib therapy between 2009 and 2015. The relationship of several toxicities with tumor response was examined. Grade 2, or more severe, common adverse events (AEs) included skin rash in 17 patients (35 %), diarrhea in 19 (39 %) and mucositis in 15 (31 %). Of these, the number of patients who developed ≥Grade 2 AEs during the first week after the initiation of afatinib therapy was: five patients had skin rash (10 %), 12 patients had diarrhea (25 %) and four patients had mucositis (8 %). As for an objective response, 21 (43 %) of the 49 had a partial response. Associating the AEs with the antitumor effect, those who had a ≥Grade 2 skin rash within the first week tended to have a greater tumor response compared with those without a rash (80 vs. 39 %; p = 0.077). Our small study demonstrated that the early development of a skin rash might be associated with the response to afatinib monotherapy.
         datePublished:2016-03-31T00:00:00Z
         dateModified:2016-03-31T00:00:00Z
         pageStart:1005
         pageEnd:1009
         sameAs:https://doi.org/10.1007/s00280-015-2910-9
         keywords:
            Lung cancer
            Afatinib
            Skin rash
            Response
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:77
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kenichiro Kudo
               affiliation:
                     name:Okayama University Hospital
                     address:
                        name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katsuyuki Hotta
               affiliation:
                     name:Okayama University Hospital
                     address:
                        name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
                     name:Okayama University Hospital
                     address:
                        name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Akihiro Bessho
               affiliation:
                     name:Japanese Red Cross Okayama Hospital
                     address:
                        name:Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Naoyuki Nogami
               affiliation:
                     name:NHO Shikoku Cancer Center
                     address:
                        name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshiyuki Kozuki
               affiliation:
                     name:NHO Shikoku Cancer Center
                     address:
                        name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shoichi Kuyama
               affiliation:
                     name:NHO Iwakuni Medical Center
                     address:
                        name:Department of Respiratory Medicine, NHO Iwakuni Medical Center, Iwakuni, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Koji Inoue
               affiliation:
                     name:Ehime Prefectural Central Hospital
                     address:
                        name:Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shingo Harita
               affiliation:
                     name:Chugoku Central Hospital
                     address:
                        name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshiaki Okada
               affiliation:
                     name:Chugoku Central Hospital
                     address:
                        name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kenichi Gemba
               affiliation:
                     name:NHO Fukuyama Medical Center
                     address:
                        name:Department of Respiratory Medicine, NHO Fukuyama Medical Center, Fukuyama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masanori Fujii
               affiliation:
                     name:Japanese Red Cross Kobe Hospital
                     address:
                        name:Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nagio Takigawa
               affiliation:
                     name:Kawasaki Medical School
                     address:
                        name:Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Naohiro Oda
               affiliation:
                     name:Okayama University Hospital
                     address:
                        name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mitsune Tanimoto
               affiliation:
                     name:Okayama University Hospital
                     address:
                        name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katsuyuki Kiura
               affiliation:
                     name:Okayama University Hospital
                     address:
                        name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience
      description:Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are now key agents in treating EGFR-mutant non-small cell lung cancer (NSCLC). The efficacy of gefitinib or erlotinib monotherapy can be predicted by the development of a skin rash. However, it has not been fully evaluated if this is the case with afatinib monotherapy. We retrospectively studied 49 consecutive patients with EGFR-mutant NSCLC who received afatinib therapy between 2009 and 2015. The relationship of several toxicities with tumor response was examined. Grade 2, or more severe, common adverse events (AEs) included skin rash in 17 patients (35 %), diarrhea in 19 (39 %) and mucositis in 15 (31 %). Of these, the number of patients who developed ≥Grade 2 AEs during the first week after the initiation of afatinib therapy was: five patients had skin rash (10 %), 12 patients had diarrhea (25 %) and four patients had mucositis (8 %). As for an objective response, 21 (43 %) of the 49 had a partial response. Associating the AEs with the antitumor effect, those who had a ≥Grade 2 skin rash within the first week tended to have a greater tumor response compared with those without a rash (80 vs. 39 %; p = 0.077). Our small study demonstrated that the early development of a skin rash might be associated with the response to afatinib monotherapy.
      datePublished:2016-03-31T00:00:00Z
      dateModified:2016-03-31T00:00:00Z
      pageStart:1005
      pageEnd:1009
      sameAs:https://doi.org/10.1007/s00280-015-2910-9
      keywords:
         Lung cancer
         Afatinib
         Skin rash
         Response
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:77
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kenichiro Kudo
            affiliation:
                  name:Okayama University Hospital
                  address:
                     name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katsuyuki Hotta
            affiliation:
                  name:Okayama University Hospital
                  address:
                     name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
                  name:Okayama University Hospital
                  address:
                     name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Akihiro Bessho
            affiliation:
                  name:Japanese Red Cross Okayama Hospital
                  address:
                     name:Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Naoyuki Nogami
            affiliation:
                  name:NHO Shikoku Cancer Center
                  address:
                     name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshiyuki Kozuki
            affiliation:
                  name:NHO Shikoku Cancer Center
                  address:
                     name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shoichi Kuyama
            affiliation:
                  name:NHO Iwakuni Medical Center
                  address:
                     name:Department of Respiratory Medicine, NHO Iwakuni Medical Center, Iwakuni, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Koji Inoue
            affiliation:
                  name:Ehime Prefectural Central Hospital
                  address:
                     name:Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shingo Harita
            affiliation:
                  name:Chugoku Central Hospital
                  address:
                     name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshiaki Okada
            affiliation:
                  name:Chugoku Central Hospital
                  address:
                     name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kenichi Gemba
            affiliation:
                  name:NHO Fukuyama Medical Center
                  address:
                     name:Department of Respiratory Medicine, NHO Fukuyama Medical Center, Fukuyama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masanori Fujii
            affiliation:
                  name:Japanese Red Cross Kobe Hospital
                  address:
                     name:Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nagio Takigawa
            affiliation:
                  name:Kawasaki Medical School
                  address:
                     name:Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Naohiro Oda
            affiliation:
                  name:Okayama University Hospital
                  address:
                     name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mitsune Tanimoto
            affiliation:
                  name:Okayama University Hospital
                  address:
                     name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katsuyuki Kiura
            affiliation:
                  name:Okayama University Hospital
                  address:
                     name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:77
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Okayama University Hospital
      address:
         name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
         type:PostalAddress
      name:Okayama University Hospital
      address:
         name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
         type:PostalAddress
      name:Okayama University Hospital
      address:
         name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
         type:PostalAddress
      name:Japanese Red Cross Okayama Hospital
      address:
         name:Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan
         type:PostalAddress
      name:NHO Shikoku Cancer Center
      address:
         name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
         type:PostalAddress
      name:NHO Shikoku Cancer Center
      address:
         name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
         type:PostalAddress
      name:NHO Iwakuni Medical Center
      address:
         name:Department of Respiratory Medicine, NHO Iwakuni Medical Center, Iwakuni, Japan
         type:PostalAddress
      name:Ehime Prefectural Central Hospital
      address:
         name:Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Japan
         type:PostalAddress
      name:Chugoku Central Hospital
      address:
         name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
         type:PostalAddress
      name:Chugoku Central Hospital
      address:
         name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
         type:PostalAddress
      name:NHO Fukuyama Medical Center
      address:
         name:Department of Respiratory Medicine, NHO Fukuyama Medical Center, Fukuyama, Japan
         type:PostalAddress
      name:Japanese Red Cross Kobe Hospital
      address:
         name:Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan
         type:PostalAddress
      name:Kawasaki Medical School
      address:
         name:Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan
         type:PostalAddress
      name:Okayama University Hospital
      address:
         name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
         type:PostalAddress
      name:Okayama University Hospital
      address:
         name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
         type:PostalAddress
      name:Okayama University Hospital
      address:
         name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kenichiro Kudo
      affiliation:
            name:Okayama University Hospital
            address:
               name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Katsuyuki Hotta
      affiliation:
            name:Okayama University Hospital
            address:
               name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
            name:Okayama University Hospital
            address:
               name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Akihiro Bessho
      affiliation:
            name:Japanese Red Cross Okayama Hospital
            address:
               name:Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Naoyuki Nogami
      affiliation:
            name:NHO Shikoku Cancer Center
            address:
               name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
               type:PostalAddress
            type:Organization
      name:Toshiyuki Kozuki
      affiliation:
            name:NHO Shikoku Cancer Center
            address:
               name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
               type:PostalAddress
            type:Organization
      name:Shoichi Kuyama
      affiliation:
            name:NHO Iwakuni Medical Center
            address:
               name:Department of Respiratory Medicine, NHO Iwakuni Medical Center, Iwakuni, Japan
               type:PostalAddress
            type:Organization
      name:Koji Inoue
      affiliation:
            name:Ehime Prefectural Central Hospital
            address:
               name:Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Japan
               type:PostalAddress
            type:Organization
      name:Shingo Harita
      affiliation:
            name:Chugoku Central Hospital
            address:
               name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
               type:PostalAddress
            type:Organization
      name:Toshiaki Okada
      affiliation:
            name:Chugoku Central Hospital
            address:
               name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
               type:PostalAddress
            type:Organization
      name:Kenichi Gemba
      affiliation:
            name:NHO Fukuyama Medical Center
            address:
               name:Department of Respiratory Medicine, NHO Fukuyama Medical Center, Fukuyama, Japan
               type:PostalAddress
            type:Organization
      name:Masanori Fujii
      affiliation:
            name:Japanese Red Cross Kobe Hospital
            address:
               name:Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan
               type:PostalAddress
            type:Organization
      name:Nagio Takigawa
      affiliation:
            name:Kawasaki Medical School
            address:
               name:Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Naohiro Oda
      affiliation:
            name:Okayama University Hospital
            address:
               name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Mitsune Tanimoto
      affiliation:
            name:Okayama University Hospital
            address:
               name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
      name:Katsuyuki Kiura
      affiliation:
            name:Okayama University Hospital
            address:
               name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
      name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
      name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
      name:Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan
      name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
      name:Department of Thoracic Oncology and Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan
      name:Department of Respiratory Medicine, NHO Iwakuni Medical Center, Iwakuni, Japan
      name:Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama, Japan
      name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
      name:Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama, Japan
      name:Department of Respiratory Medicine, NHO Fukuyama Medical Center, Fukuyama, Japan
      name:Department of Respiratory Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan
      name:Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan
      name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
      name:Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
      name:Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(112)

• https://www.springernature.com/gp/authors's financial summary
• How much profit does https://link.springernature.com/home/ make?
• How much profit is https://order.springer.com/public/cart making per month?
• How much does https://submission.springernature.com/new-submission/280/3 generate monthly?
• Discover the revenue of https://www.springernature.com/gp/librarians/licensing/agc/journals
• How much does https://doi.org/10.1056%2FNEJMoa040938 earn?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15118073?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Activating%20mutations%20in%20the%20epidermal%20growth%20factor%20receptor%20underlying%20responsiveness%20of%20non-small-cell%20lung%20cancer%20to%20gefitinib&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040938&volume=350&pages=2129-2139&publication_year=2004&author=Lynch%2CTJ&author=Bell%2CDW&author=Sordella%2CR?
• https://doi.org/10.1126%2Fscience.1099314's total income per month
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15118125 bring in each month?
• Find out how much http://scholar.google.com/scholar_lookup?&title=EGFR%20mutations%20in%20lung%20cancer%3A%20correlation%20with%20clinical%20response%20to%20gefitinib%20therapy&journal=Science&doi=10.1126%2Fscience.1099314&volume=304&pages=1497-1500&publication_year=2004&author=Paez%2CJG&author=Janne%2CPA&author=Lee%2CJC earns monthly
• How much does https://doi.org/10.1073%2Fpnas.0405220101 bring in each month?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15329413
• Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC516528
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=EGF%20receptor%20gene%20mutations%20are%20common%20in%20lung%20cancers%20from%20%E2%80%9Cnever%20smokers%E2%80%9D%20and%20are%20associated%20with%20sensitivity%20of%20tumors%20to%20gefitinib%20and%20erlotinib&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0405220101&volume=101&pages=13306-13311&publication_year=2004&author=Pao%2CW&author=Miller%2CV&author=Zakowski%2CM?
• What's the monthly money flow for https://doi.org/10.1111%2Fj.1742-4658.2009.07448.x?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19922469 generate monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Epidermal%20growth%20factor%20receptor%20in%20relation%20to%20tumor%20development%3A%20EGFR%20gene%20and%20cancer&journal=FEBS%20J&doi=10.1111%2Fj.1742-4658.2009.07448.x&volume=277&pages=301-308&publication_year=2010&author=Mitsudomi%2CT&author=Yatabe%2CY?
• How much does https://doi.org/10.1056%2FNEJMoa0810699 pull in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19692680 generate monthly?
• See how much http://scholar.google.com/scholar_lookup?&title=Gefitinib%20or%20carboplatin-paclitaxel%20in%20pulmonary%20adenocarcinoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0810699&volume=361&pages=947-957&publication_year=2009&author=Mok%2CTS&author=Wu%2CYL&author=Thongprasert%2CS makes per month
• How much money does https://doi.org/10.1056%2FNEJMoa0909530 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20573926 pull in?
• See how much http://scholar.google.com/scholar_lookup?&title=Gefitinib%20or%20chemotherapy%20for%20non-small-cell%20lung%20cancer%20with%20mutated%20EGFR&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0909530&volume=362&pages=2380-2388&publication_year=2010&author=Maemondo%2CM&author=Inoue%2CA&author=Kobayashi%2CK makes per month
• What's the revenue for https://doi.org/10.1016%2FS1470-2045%2811%2970184-X?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21783417 is on a monthly basis
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Erlotinib%20versus%20chemotherapy%20as%20first-line%20treatment%20for%20patients%20with%20advanced%20EGFR%20mutation-positive%20non-small-cell%20lung%20cancer%20%28OPTIMAL%2C%20CTONG-0802%29%3A%20a%20multicentre%2C%20open-label%2C%20randomised%2C%20phase%203%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2811%2970184-X&volume=12&pages=735-742&publication_year=2011&author=Zhou%2CC&author=Wu%2CYL&author=Chen%2CG
• What is the monthly revenue of https://doi.org/10.1016%2FS1470-2045%2811%2970393-X?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22285168?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Erlotinib%20versus%20standard%20chemotherapy%20as%20first-line%20treatment%20for%20European%20patients%20with%20advanced%20EGFR%20mutation-positive%20non-small%20cell%20lung%20cancer%20%28EURTAC%29%3A%20a%20multicentre%2C%20open-label%2C%20randomized%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2811%2970393-X&volume=13&pages=239-246&publication_year=2012&author=Rosell%2CR&author=Carcereny%2CE&author=Gervais%2CR?
• How much does https://doi.org/10.1200%2FJCO.2012.44.2806 bring in each month?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23816960?
• How much income is http://scholar.google.com/scholar_lookup?&title=Phase%20III%20study%20of%20afatinib%20or%20cisplatin%20plus%20pemetrexed%20in%20patients%20with%20metastatic%20lung%20adenocarcinoma%20with%20EGFR%20mutations&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2012.44.2806&volume=31&pages=3327-3334&publication_year=2013&author=Sequist%2CLV&author=Yang%2CJC&author=Yamamoto%2CN earning monthly?
• What's the revenue for https://doi.org/10.1016%2FS1470-2045%2813%2970604-1?
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24439929's earnings
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Afatinib%20versus%20cisplatin%20plus%20gemcitabine%20for%20first-line%20treatment%20of%20Asian%20patients%20with%20advanced%20non-small-cell%20lung%20cancer%20harbouring%20EGFR%20mutations%20%28LUX-Lung%206%29%3A%20an%20open-label%2C%20randomised%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2813%2970604-1&volume=15&pages=213-222&publication_year=2014&author=Wu%2CYL&author=Zhou%2CC&author=Hu%2CCP bring in?
• What's the financial outcome of https://doi.org/10.1200%2FJCO.2005.04.9890?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16622257
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Gefitinib%20therapy%20in%20advanced%20bronchioloalveolar%20carcinoma%3A%20Southwest%20Oncology%20Group%20Study%20S0126&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.9890&volume=24&pages=1807-1813&publication_year=2006&author=West%2CHL&author=Franklin%2CWA&author=McCoy%2CJ
• Explore the financials of https://doi.org/10.1056%2FNEJMoa050753
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16014882?
• How much does http://scholar.google.com/scholar_lookup?&title=Erlotinib%20in%20previously%20treated%20non-small-cell%20lung%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa050753&volume=353&pages=123-132&publication_year=2005&author=Shepherd%2CFA&author=Rodrigues%2CPJ&author=Ciuleanu%2CT pull in monthly?
• Learn about the earnings of https://doi.org/10.1016%2Fj.ejca.2008.10.026
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774 bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumors%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ gross monthly?
• What's the monthly income of https://doi.org/10.1158%2F1078-0432.CCR-06-0260?
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17062680's earnings
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Erlotinib%20for%20frontline%20treatment%20of%20advanced%20non-small%20cell%20lung%20cancer%3A%20a%20phase%20II%20study&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0260&volume=12&pages=6049-6055&publication_year=2006&author=Giaccone%2CG&author=Gallegos%20Ruiz%2CM&author=Chevalier%2CT
• What's the financial outcome of https://doi.org/10.1158%2F1078-0432.CCR-05-1247?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16322304
• http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20of%20gefitinib%20250%C2%A0mg%20daily%20in%20patients%20with%20recurrent%20and%2For%20metastatic%20squamous%20cell%20carcinoma%20of%20the%20head%20and%20neck&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-1247&volume=11&pages=8418-8424&publication_year=2005&author=Cohen%2CEE&author=Kane%2CMA&author=List%2CMA's total income per month
• Profit of https://doi.org/10.1200%2FJCO.2007.13.1128
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18309947 generate monthly?
• http://scholar.google.com/scholar_lookup?&title=Pharmacogenomic%20and%20pharmacokinetic%20determinants%20of%20erlotinib%20toxicity&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.13.1128&volume=26&pages=1119-1127&publication_year=2008&author=Rudin%2CCM&author=Liu%2CW&author=Desai%2CA income
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23532985 make?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Population%20pharmacokinetics%2Fpharmacodynamics%20of%20erlotinib%20and%20pharmacogenomic%20analysis%20of%20plasma%20and%20cerebrospinal%20fluid%20drug%20concentrations%20in%20Japanese%20patients%20with%20non-small%20cell%20lung%20cancer&journal=Clin%20Pharmacokinet&doi=10.1007%2Fs40262-013-0058-5&volume=52&pages=593-609&publication_year=2013&author=Fukudo%2CM&author=Ikemi%2CY&author=Togashi%2CY
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23813493
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Pharmacokinetics%20of%20afatinib%2C%20a%20selective%20irreversible%20ErbB%20family%20blocker%2C%20in%20patients%20with%20advanced%20solid%20tumours&journal=Clin%20Pharmacokinet&doi=10.1007%2Fs40262-013-0091-4&volume=52&pages=1101-1109&publication_year=2013&author=Wind%2CS&author=Schmid%2CM&author=Erhardt%2CJ bring in?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20458561 generate?
• Find out how much http://scholar.google.com/scholar_lookup?&title=The%20relationship%20between%20drug%20exposure%20and%20clinical%20outcomes%20of%20non-small%20cell%20lung%20cancer%20patients%20treated%20with%20gefitinib&journal=Med%20Oncol&doi=10.1007%2Fs12032-010-9541-0&volume=28&pages=697-702&publication_year=2011&author=Zhao%2CYY&author=Li%2CS&author=Zhang%2CY earns monthly
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24121455?
• How much income is http://scholar.google.com/scholar_lookup?&title=Phase%20II%20trial%20of%20erlotinib%20in%20patients%20with%20advanced%20non-small-cell%20lung%20cancer%20harboring%20epidermal%20growth%20factor%20receptor%20mutations%3A%20additive%20analysis%20of%20pharmacokinetics&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-013-2307-6&volume=72&pages=1299-1304&publication_year=2013&author=Motoshima%2CK&author=Nakamura%2CY&author=Sano%2CK earning monthly?
• How much cash flow does https://citation-needed.springer.com/v2/references/10.1007/s00280-015-2910-9?format=refman&flavour=references have monthly?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenichiro%20Kudo produce monthly?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenichiro%20Kudo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katsuyuki%20Hotta
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katsuyuki%20Hotta%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akihiro%20Bessho
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akihiro%20Bessho%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Naoyuki%20Nogami pull in monthly?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Naoyuki%20Nogami%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toshiyuki%20Kozuki net monthly?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toshiyuki%20Kozuki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shoichi%20Kuyama
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shoichi%20Kuyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Koji%20Inoue generate monthly?
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Koji%20Inoue%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shingo%20Harita?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shingo%20Harita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toshiaki%20Okada?
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toshiaki%20Okada%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenichi%20Gemba?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenichi%20Gemba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masanori%20Fujii
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masanori%20Fujii%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nagio%20Takigawa rake in every month?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nagio%20Takigawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Naohiro%20Oda generate?
• How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Naohiro%20Oda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
• Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mitsune%20Tanimoto
• What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mitsune%20Tanimoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katsuyuki%20Kiura's gross income?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katsuyuki%20Kiura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=Development%20of%20a%20skin%20rash%20within%20the%20first%20week%20and%20the%20therapeutic%20effect%20in%20afatinib%20monotherapy%20for%20EGFR-mutant%20non-small%20cell%20lung%20cancer%20%28NSCLC%29%3A%20Okayama%20Lung%20Cancer%20Study%20Group%20experience&author=Kenichiro%20Kudo%20et%20al&contentID=10.1007%2Fs00280-015-2910-9©right=Springer-Verlag%20Berlin%20Heidelberg&publication=0344-5704&publicationDate=2016-03-31&publisherName=SpringerNature&orderBeanReset=true?
• How much does https://crossmark.crossref.org/dialog/?doi=10.1007/s00280-015-2910-9 gross monthly?
• How much income does https://citation-needed.springer.com/v2/references/10.1007/s00280-015-2910-9?format=refman&flavour=citation have?
• Monthly income for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• How much income is https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research earning monthly?
• Monthly income for https://www.springernature.com/gp/products
• How much does https://www.springernature.com/gp/librarians gross monthly?
• What's the income of https://www.springernature.com/gp/societies?
• What's the financial outcome of https://www.springernature.com/gp/partners?
• What's the monthly money flow for https://www.springer.com/?
• How much does https://www.nature.com/ pull in monthly?
• How much does https://www.biomedcentral.com/ make?
• How much does https://www.palgrave.com/ earn?
• What's the financial outcome of https://www.apress.com/?
• What's the financial gain of https://www.springernature.com/gp/legal/ccpa?
• https://www.springernature.com/gp/info/accessibility's revenue stream
• https://support.springernature.com/en/support/home's financial summary
• How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations bring in each month?
• How much does https://www.springernature.com/ pull in monthly?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref